XML 100 R77.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment Information - Business Segment Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2021
Segment Reporting Information [Line Items]      
Net sales $ 3,593,200 $ 3,308,400 $ 2,922,500
Operating income (loss) 533,100 507,600 505,800
Interest expense 105,300 57,300 23,100
Other expense (income), net 14,900 (25,000) (8,800)
Income before income taxes 412,900 475,300 491,500
Identifiable assets 11,658,900 11,492,300 9,606,200
Depreciation expense 181,500 166,600 163,200
Amortization expense 186,200 179,500 146,100
Capital expenditures 392,500 242,000 214,400
CooperVision      
Segment Reporting Information [Line Items]      
Net sales 2,423,700 2,243,300 2,152,000
CooperSurgical      
Segment Reporting Information [Line Items]      
Net sales 1,169,500 1,065,100 770,500
Operating Segments | CooperVision      
Segment Reporting Information [Line Items]      
Net sales 2,423,700 2,243,300 2,152,000
Operating income (loss) 587,700 494,300 481,300
Identifiable assets 7,044,000 6,778,900 6,965,900
Depreciation expense 156,900 144,500 148,300
Amortization expense 32,900 32,300 35,700
Capital expenditures 364,400 223,000 190,000
Operating Segments | CooperSurgical      
Segment Reporting Information [Line Items]      
Net sales 1,169,500 1,065,100 770,500
Operating income (loss) 16,100 67,100 71,800
Identifiable assets 4,351,800 4,407,800 2,395,600
Depreciation expense 24,600 22,100 14,900
Amortization expense 153,300 147,200 110,400
Capital expenditures 28,100 19,000 24,400
Corporate      
Segment Reporting Information [Line Items]      
Net sales 0 0 0
Operating income (loss) (70,700) (53,800) (47,300)
Identifiable assets 263,100 305,600 244,700
Depreciation expense 0 0 0
Amortization expense 0 0 0
Capital expenditures $ 0 $ 0 $ 0